Advertisement

Protein Stability and Characterization

  • Atanas KoulovEmail author
Chapter

Abstract

Throughout the development process of protein therapeutics a broad array of analytical techniques is applied on a routine basis to measure various molecular attributes. These measurements are carried out in the context of the quality control system of the product (routine monitoring of the product quality e.g. regarding stability during long-term storage) or as various characterization studies aimed at broadening the knowledge of the molecule. All stages of product development rely on analytical support: cell line and purification development, formulation development, compatibility studies, comparability exercises and also assessment of stability during production, storage and shipping.

The successful design of product control and characterization strategies to support biotherapeutic development requires intimate knowledge of protein analytical chemistry: the potential modifications that may occur in the protein molecule and the analytical techniques capable of measuring these modifications.

Keywords

(Physico-chemical) protein analytical techniques Protein degradation Protein modifications Protein chemistry Bioassays 

Notes

Acknowledgements

This chapter is a re-work of part (including a number of figures) of the chapter “Biophysical and Biochemical Analysis of Recombinant Proteins”, by Tsutomu Arakawa and John Philo, which appeared in the previous editions of this book—cf. fourth edition, 2013. Despite the significant changes made to the original chapter, it still contains fragments of the excellent original text by Arakawa and Philo.

The author thanks Abbas Razvi and Marigone Lenjani for providing chromatograms and electropherograms shown in this chapter.

Further Reading

  1. Arbogast LW, Brinson RG, Marino JP (2015) Mapping monoclonal antibody structure by 2D 13C NMR at natural abundance. Anal Chem 87(7):3556–3561CrossRefGoogle Scholar
  2. Berkowitz SA, Engen JR, Mazzeo JR, Jones GB (2012) Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars. Nat Rev Drug Discov 11(7):527–540CrossRefGoogle Scholar
  3. Butler JE (ed) (1991) Immunochemistry of solid-phase immunoassay. CRC Press, Boca RatonGoogle Scholar
  4. Cavanagh J, Fairbrother WJ, Skelton NJ (2007) Protein NMR spectroscopy: principles and practice book, 2nd edn. Academic Press, San DiegoGoogle Scholar
  5. Chirino AJ, Mire-Sluis A (2004) Characterizing biological products and assessing comparability following manufacturing changes. Nat Biotechnol 22(11):1383–1391CrossRefGoogle Scholar
  6. Coligan J, Dunn B, Ploegh H, Speicher D, Wingfield P (eds) (1995) Current protocols in protein science. Wiley, New YorkGoogle Scholar
  7. Crabb JW (ed) (1995) Techniques in protein chemistry VI. Academic, San DiegoGoogle Scholar
  8. Domon B, Aebersold R (2006) Mass spectrometry and protein analysis. Science 312(5771):212–217CrossRefGoogle Scholar
  9. Du Y, Walsh A, Ehrick R, Xu W, May K, Liu H (2012) Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies. MAbs 4(5):578–585CrossRefGoogle Scholar
  10. Dunbar BS (1994) Protein blotting: a practical approach. Oxford University Press, New YorkGoogle Scholar
  11. Fekete S, Guillarme D, Sandra P, Sandra K (2016) Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals. Anal Chem 88(1):480–507CrossRefGoogle Scholar
  12. Folzer E, Diepold C, Bomans K, Finkler C, Schmidt R, Bulau P, Huwyler J, Mahler H-C, Koulov AV (2015) Selective oxidation of methionine and tryptophan residues in a therapeutic IgG1 molecule. J Pharm Sci 104:2824–2831CrossRefGoogle Scholar
  13. Gahoual R, Beck A, Leize-Wagner E, François YN (2016) Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products. J Chromatogr B Analyt Technol Biomed Life Sci 1032:61–78CrossRefGoogle Scholar
  14. Hames BD, Rickwood D (eds) (1990) Gel electrophoresis of proteins: a practical approach, 2nd edn. IRL Press, New YorkGoogle Scholar
  15. Henderson R (2018) From electron crystallography to single particle Cryo EM (Nobel lecture). Angew Chem Int Ed Engl 57(34):10804–10825CrossRefGoogle Scholar
  16. Jiskoot W, Crommelin DJA (eds) (2005) Methods for structural analysis of protein pharmaceuticals. AAPS Press, ArlingtonGoogle Scholar
  17. Kahle J, Wätzig H (2018) Determination of protein charge variants with (imaged) capillary isoelectric focusing and capillary zone electrophoresis. Electrophoresis 39(20):2492–2511CrossRefGoogle Scholar
  18. Kaltashov IA, Bobst CE, Abzalimov RR, Wang G, Baykal B, Wang S (2012) Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv 30(1):210–222CrossRefGoogle Scholar
  19. Liu H, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J (2008) Heterogeneity of monoclonal antibodies. J Pharm Sci 97(7):2426–2447CrossRefGoogle Scholar
  20. McEwen CN, Larsen BS (eds) (1998) Mass spectrometry of biological materials, 2nd edn. Dekker, New YorkGoogle Scholar
  21. Moritz B, Schnaible V, Kiessig S, Heyne A, Wild M, Finkler C, Christians S, Mueller K, Zhang L, Furuya K, Hassel M, Hamm M, Rustandi R, He Y, Solano OS, Whitmore C, Park SA, Hansen D, Santos M, Lies M (2015) Evaluation of capillary zone electrophoresis for charge heterogeneity testing of monoclonal antibodies. J Chromatogr B Analyt Technol Biomed Life Sci 983-984:101–110CrossRefGoogle Scholar
  22. Müllertz A, Perrie Y, Rades T (eds) (2016) Analytical techniques in the pharmaceutical sciences. Springer, New YorkGoogle Scholar
  23. Pace CN, Grimsley GR, Scholtz JM, Shaw KL (2014) Protein stability. In: eLS. Wiley, ChichesterGoogle Scholar
  24. Parr MK, Montacir O, Montacir H (2016) Physicochemical characterization of biopharmaceuticals. J Pharm Biomed Anal 130:366–389CrossRefGoogle Scholar
  25. Ponniah G, Nowak C, Neill A, Liu H (2017) Characterization of charge variants of a monoclonal antibody using weak anion exchange chromatography at subunit levels. Anal Biochem 520:49–57CrossRefGoogle Scholar
  26. Rathore D, Faustino A, Schiel J, Pang E, Boyne M, Rogstad S (2018) The role of mass spectrometry in the characterization of biologic protein products. Expert Rev Proteomics 15(5):431–449CrossRefGoogle Scholar
  27. Ríos Quiroz A, Lamerz J, Da Cunha T, Boillon A, Adler M, Finkler C, Huwyler J, Schmidt R, Mahler H-M, Koulov AV (2016) Factors governing the precision of subvisible particle measurement methods—a case study with a low-concentration therapeutic protein product in a prefilled syringe. Pharm Res 33:450–461CrossRefGoogle Scholar
  28. Salas-Solano O, Felten O (2008) Capillary electrophoresis methods for pharmaceutical analysis. Sep Sci Technol 9:401Google Scholar
  29. Shirley BA (ed) (1995) Protein stability and folding. Humana Press, TotowaGoogle Scholar
  30. Strege MA, Lagu AL (eds) (2004) Capillary electrophoresis of proteins and peptides. Humana Press, TotowaGoogle Scholar
  31. Thorpe R, Wadhwa M, Mire-Sluis A (1997) The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology. Dev Biol Stand 91:79–88PubMedGoogle Scholar
  32. Vlasak J, Ionescu R (2011) Fragmentation of monoclonal antibodies. MAbs 63:253–263CrossRefGoogle Scholar
  33. Vlasak J, Ionescu R (2008) Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods. Curr Pharm Biotechnol 9:468–481CrossRefGoogle Scholar
  34. Wei H, Mo J, Tao L, Russell RJ, Tymiak AA, Chen G, Iacob RE, Engen JR (2014) Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications. Drug Discov Today 19(1):95–102CrossRefGoogle Scholar
  35. Wild D (ed) (2013) The immunoassay handbook theory and applications of ligand binding, ELISA and related techniques, 4th edn. Elsevier, New YorkGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Analytical Development and Quality Control, Drug Product ServicesLonza AGBaselSwitzerland

Personalised recommendations